Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CAPN1 | P07384 | 1/20 | 0.43 |
| ▸ | BCHE | P06276 | 2/20 | 0.39 |
| ▸ | ACHE | P22303 | 2/20 | 0.39 |
| ▸ | MEN1 | O00255 | 1/20 | 0.38 |
| ▸ | GAA | P10253 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.38 |
| ▸ | CTSK | P43235 | 8/20 | 0.37 |
| ▸ | CTSS | P25774 | 4/20 | 0.37 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.35 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.35 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.35 |
| ▸ | HTT | P42858 | 1/20 | 0.35 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.34 |
| ▸ | ATM | Q13315 | 1/20 | 0.34 |
| ▸ | KLK5 | Q9Y337 | 2/20 | 0.34 |
| ▸ | KLK7 | P49862 | 1/20 | 0.34 |
| ▸ | ACE | P12821 | 1/20 | 0.34 |
| ▸ | MAPT | P10636 | 1/20 | 0.34 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.34 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15498944 | 0.91 | CAPN1 (0.44) | CAPN1MEN1GAAKMT2ACTSK | |
| SCHEMBL17747017 | 0.83 | CTSK (0.40) | CTSKCTSSCYP1A2CYP2C9CYP2C19 | |
| SCHEMBL17747019 | 0.83 | CTSK (0.40) | CTSKCTSSCYP1A2CYP2C9CYP2C19 | |
| SCHEMBL17381374 | 0.82 | TDP1 (0.43) | MEN1GAAKMT2ATDP1ATM | |
| SCHEMBL30346421 | 0.82 | BCHE (0.38) | CAPN1BCHEACHEMEN1KMT2A | |
| SCHEMBL24073184 | 0.81 | BCHE (0.51) | CAPN1BCHEACHEMEN1GAA | |
| SCHEMBL23280888 | 0.81 | CAPN1 (0.44) | CAPN1BCHEACHEMEN1KMT2A | |
| SCHEMBL15498945 | 0.81 | CAPN1 (0.47) | CAPN1MEN1GAAKMT2ACTSK | |
| SCHEMBL21541108 | 0.81 | TDP1 (0.44) | MEN1GAAKMT2ATDP1ATM | |
| SCHEMBL29796125 | 0.80 | CAPN1 (0.46) | CAPN1MEN1GAAKMT2ACTSK |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9309284-B2 | Macrocyclic and peptidomimetic compounds as broad-spectrum antivirals against 3C or 3C-like proteases of picornaviruses, caliciviruses and coronaviruses | Kansas State University Reasearch Foundation (US) | 2016-04-12 | — | — | US | disclosed |
| US-9309284-B2 | Macrocyclic and peptidomimetic compounds as broad-spectrum antivirals against 3C or 3C-like proteases of picornaviruses, caliciviruses and coronaviruses | Kansas State University Reasearch Foundation (US) | 2016-04-12 | — | — | US | disclosed |
| US-20150133368-A1 | MACROCYCLIC AND PEPTIDOMIMETIC COMPOUNDS AS BROAD-SPECTRUM ANTIVIRALS AGAINST 3C OR 3C-LIKE PROTEASES OF PICORNAVIRUSES, CALICIVIRUSES AND CORONAVIRUSES | WICHITA STATE UNIVERSITY | 2015-05-14 | — | — | US | disclosed |
| US-20150133368-A1 | MACROCYCLIC AND PEPTIDOMIMETIC COMPOUNDS AS BROAD-SPECTRUM ANTIVIRALS AGAINST 3C OR 3C-LIKE PROTEASES OF PICORNAVIRUSES, CALICIVIRUSES AND CORONAVIRUSES | WICHITA STATE UNIVERSITY | 2015-05-14 | — | — | US | disclosed |
| EP-2844249-A1 | MACROCYCLIC AND PEPTIDOMIMETIC COMPOUNDS AS BROAD-SPECTRUM ANTIVIRALS AGAINST 3C OR 3C-LIKE PROTEASES OF PICORNAVIRUSES, CALICIVIRUSES AND CORONAVIRUSES | Kansas State University Research Foundation (US) | 2015-03-11 | — | — | EP | disclosed |
| WO-2013166319-A1 | MACROCYCLIC AND PEPTIDOMIMETIC COMPOUNDS AS BROAD-SPECTRUM ANTIVIRALS AGAINST 3C OR 3C-LIKE PROTEASES OF PICORNAVIRUSES, CALICIVIRUSES AND CORONAVIRUSES | KANSAS STATE UNIVERSITY RESEARCH FOUNDATION (US) | 2013-11-07 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150133368-A1 | MACROCYCLIC AND PEPTIDOMIMETIC COMPOUNDS AS BROAD-SPECTRUM ANTIVIRALS AGAINST 3C OR 3C-LIKE PROTEASES OF PICORNAVIRUSES, CALICIVIRUSES AND CORONAVIRUSES | CTSV, CTSL, GTF3C3 | CAPN1 82/4885BCHE 1284/4885ACHE 2378/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.